SciFluor reports Phase I/II data for SF0166 in wet AMD

SciFluor Life Sciences Inc. (Cambridge, Mass.) reported top-line data from 42 evaluable patients with wet age-related macular degeneration (AMD) in a Phase I/II trial showing that

Read the full 261 word article

User Sign In